Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
66
EMBC Quote, Financials, Valuation and Earnings
Last price:
$12.08
Seasonality move
:
-8.46%
Day range:
$11.94 - $12.16
52-week range:
$9.20 - $21.23
Dividend yield:
4.97%
P/E ratio:
7.42x
P/S ratio:
0.66x
P/B ratio:
--
Volume:
220K
Avg. volume:
762K
1-year change:
-40.43%
Market cap:
$706.8M
Revenue:
$1.1B
EPS (TTM):
$1.63
Analysts' Opinion
-
Consensus RatingEmbecta Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.67, Embecta Corp. has an estimated upside of 37.97% from its current price of $12.08.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $11.00 representing 100% downside risk from its current price of $12.08.
Fair Value
-
According to the consensus of 3 analysts, Embecta Corp. has 37.97% upside to fair value with a price target of $16.67 per share.
EMBC vs. S&P 500
-
Over the past 5 trading days, Embecta Corp. has overperformed the S&P 500 by 1.1% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Embecta Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Embecta Corp. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Embecta Corp. reported revenues of $264M.
Earnings Growth
-
Embecta Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Embecta Corp. reported earnings per share of $0.45.
Enterprise value:
1.9B
EV / Invested capital:
2.42x
Price / LTM sales:
0.66x
EV / EBIT:
5.91x
EV / Revenue:
1.78x
PEG ratio (5yr expected):
0.37x
EV / Free cash flow:
10.56x
Price / Operating cash flow:
3.88x
Enterprise value / EBITDA:
5.11x
Gross Profit (TTM):
$679.4M
Return On Assets:
8.18%
Net Income Margin (TTM):
8.83%
Return On Equity:
--
Return On Invested Capital:
11.39%
Operating Margin:
24.39%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.1B | $1.1B | $286.1M | $264M | |
| Gross Profit | $749.9M | $729.3M | $679.4M | $171.3M | $156M | |
| Operating Income | $227.2M | $282.1M | $325.9M | $54.8M | $64.4M | |
| EBITDA | $259.8M | $324.6M | $377M | $66.8M | $80.1M | |
| Diluted EPS | $1.23 | $1.35 | $1.63 | $0.25 | $0.45 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $291.8M | $664.7M | $749.1M | $761M | $631.4M | |
| Total Assets | $788M | $1.1B | $1.2B | $1.3B | $1.1B | |
| Current Liabilities | $164M | $301M | $353.5M | $374M | $261.5M | |
| Total Liabilities | $193.7M | $2B | $2B | $2B | $1.8B | |
| Total Equity | $594.3M | -$891.4M | -$821.7M | -$738.3M | -$650.6M | |
| Total Debt | -- | $1.6B | $1.7B | $1.6B | $1.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $67.7M | $35.7M | $191.7M | $26.6M | $84M | |
| Cash From Investing | -$26.5M | -$15.8M | -$9.3M | -- | -$7.3M | |
| Cash From Financing | -$48.7M | -$73.4M | -$226.7M | -$36.6M | -$81.6M | |
| Free Cash Flow | $41.2M | $19.9M | $182.4M | $26.6M | $76.7M | |
EMBC
Sector
Market Cap
$706.8M
$28M
Price % of 52-Week High
56.9%
51.03%
Dividend Yield
4.97%
0%
Shareholder Yield
9.23%
-1.54%
1-Year Price Total Return
-40.43%
-17.48%
Beta (5-Year)
--
0.518
Dividend yield:
4.97%
Annualized payout:
$0.60
Payout ratio:
33.45%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$11.86
200-day SMA
Sell
Level
$12.44
Bollinger Bands (100)
Sell
Level
12.28 - 14.78
Chaikin Money Flow
Sell
Level
-24.6M
20-day SMA
Buy
Level
$11.97
Relative Strength Index (RSI14)
Sell
Level
45.28
ADX Line
Sell
Level
24.23
Williams %R
Neutral
Level
-20.9413
50-day SMA
Sell
Level
$13.18
MACD (12, 26)
Sell
Level
-0.41
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Sell
Level
-37.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.0586)
Sell
CA Score
(Annual)
Level (-3.826)
Buy
Beneish M-Score
(Annual)
Level (-3.0596)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (6.2203)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Stock Forecast FAQ
In the current month, EMBC has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The EMBC average analyst price target in the past 3 months is $16.67.
-
Where Will Embecta Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Embecta Corp. share price will rise to $16.67 per share over the next 12 months.
-
What Do Analysts Say About Embecta Corp.?
Analysts are divided on their view about Embecta Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Embecta Corp. is a Sell and believe this share price will drop from its current level to $11.00.
-
What Is Embecta Corp.'s Price Target?
The price target for Embecta Corp. over the next 1-year time period is forecast to be $16.67 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is EMBC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Embecta Corp. is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EMBC?
You can purchase shares of Embecta Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Embecta Corp. shares.
-
What Is The Embecta Corp. Share Price Today?
Embecta Corp. was last trading at $12.08 per share. This represents the most recent stock quote for Embecta Corp.. Yesterday, Embecta Corp. closed at $12.08 per share.
-
How To Buy Embecta Corp. Stock Online?
In order to purchase Embecta Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get EMBC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EMBC
Sector
P/E ratio
7.42x
23.89x
PEG ratio
0.37x
-0.01x
P/B ratio
--
1.82x
Price / LTM sales
0.66x
1.60x
Growth Metrics
EMBC
Sector
Revenue growth
-7.73%
4.62%
Earnings growth
78.54%
10.88%
Revenue (5-year growth)
-0.1%
6.5%
Earnings forecast
$0.46
-$0.21
Profitability
EMBC
Sector
Profitability FY 2025
$679.5M
$3.5M
Return on invested capital
11.39%
-31.77%
Return on assets
8.18%
-27.96%
Return on equity
--
-37.63%
Earnings Date
Last Earnings Date
Nov
25
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Feb
24
Balance Sheet
EMBC
Sector
Total cash
$228.6M
$26.3M
Short term investments
--
$25.7M
Total assets
$1.1B
$78M
Long term debt
$1.4B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
